INOVIO PHARMACEUTICALS, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -76.0% | -76.0% | -61.2% |
| FY2022 | -125.8% | -125.8% | -80.3% |
| FY2023 | -115.1% | -115.1% | -79.0% |
| FY2024 | -156.6% | -156.6% | -94.7% |
| FY2025 | -352.5% | -352.5% | -114.3% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -76.0% | -76.0% | -61.2% |
| FY2022 | -125.8% | -125.8% | -80.3% |
| FY2023 | -115.1% | -115.1% | -79.0% |
| FY2024 | -156.6% | -156.6% | -94.7% |
| FY2025 | -352.5% | -352.5% | -114.3% |